These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37788612)

  • 1. Impact of Harm Reduction Treatment with or without Pharmacotherapy on Polysubstance Use among People Experiencing Homelessness and Alcohol Use Disorder.
    Mostofi N; Collins SE
    J Addict Med; 2023 Sep-Oct 01; 17(5):574-579. PubMed ID: 37788612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.
    Collins SE; Duncan MH; Saxon AJ; Taylor EM; Mayberry N; Merrill JO; Hoffmann GE; Clifasefi SL; Ries RK
    Lancet Psychiatry; 2021 Apr; 8(4):287-300. PubMed ID: 33713622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safer-use strategies in the context of harm-reduction treatment for people experiencing homelessness and alcohol use disorder.
    Alawadhi YT; Shinagawa E; Taylor EM; Jackson C; Fragasso A; Howard M; Fan L; Kolpikova E; Karra S; Frohe T; Clifasefi SL; Duncan MH; Collins SE
    Int J Drug Policy; 2024 Jul; 129():104448. PubMed ID: 38905941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of harm reduction treatment for alcohol (HaRT-A) for people experiencing homelessness and alcohol use disorder.
    Collins SE; Clifasefi SL; Nelson LA; Stanton J; Goldstein SC; Taylor EM; Hoffmann G; King VL; Hatsukami AS; Cunningham ZL; Taylor E; Mayberry N; Malone DK; Jackson TR
    Int J Drug Policy; 2019 May; 67():24-33. PubMed ID: 30851620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jail and Emergency Department Utilization in the Context of Harm Reduction Treatment for People Experiencing Homelessness and Alcohol Use Disorder.
    Collins SE; Goldstein SC; Suprasert B; Doerr SAM; Gliane J; Song C; Orfaly VE; Moodliar R; Taylor EM; Hoffmann G
    J Urban Health; 2021 Feb; 98(1):83-90. PubMed ID: 33185824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-release Naltrexone Is Not Linked to Hepatotoxicity in Adults Experiencing Homelessness and Alcohol Use Disorder.
    Vutien P; Kim NJ; Merrill JO; Duncan MH; Ioannou GN; Collins SE
    J Addict Med; 2023 May-Jun 01; 17(3):363-366. PubMed ID: 37267194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm reduction with pharmacotherapy for homeless people with alcohol dependence: protocol for a randomized controlled trial.
    Collins SE; Saxon AJ; Duncan MH; Smart BF; Merrill JO; Malone DK; Jackson TR; Clifasefi SL; Joesch J; Ries RK
    Contemp Clin Trials; 2014 Jul; 38(2):221-34. PubMed ID: 24846619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release naltrexone and harm reduction counseling for chronically homeless people with alcohol dependence.
    Collins SE; Duncan MH; Smart BF; Saxon AJ; Malone DK; Jackson TR; Ries RK
    Subst Abus; 2015; 36(1):21-33. PubMed ID: 24779575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction treatment for smoking (HaRT-S): findings from a single-arm pilot study with smokers experiencing chronic homelessness.
    Collins SE; Nelson LA; Stanton J; Mayberry N; Ubay T; Taylor EM; Hoffmann G; Goldstein SC; Saxon AJ; Malone DK; Clifasefi SL; Okuyemi K;
    Subst Abus; 2019; 40(2):229-239. PubMed ID: 30924732
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study.
    Ellis JD; Rabinowitz JA; Ware OD; Wells J; Dunn KE; Huhn AS
    J Subst Use Addict Treat; 2023 Mar; 146():208932. PubMed ID: 36880895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual study describing patient-driven harm reduction goal-setting among people experiencing homelessness and alcohol use disorder.
    Fentress TSP; Wald S; Brah A; Leemon G; Reyes R; Alkhamees F; Kramer M; Taylor EM; Wildhood M; Frohe T; Duncan MH; Clifasefi SL; Collins SE
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):261-271. PubMed ID: 34264737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.
    Muvvala SB; O'Malley SS; Rosenheck R
    Am J Addict; 2021 Jan; 30(1):55-64. PubMed ID: 32805083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis.
    Ray LA; Meredith LR; Kiluk BD; Walthers J; Carroll KM; Magill M
    JAMA Netw Open; 2020 Jun; 3(6):e208279. PubMed ID: 32558914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to treating alcohol use disorder in people experiencing homelessness.
    Kertesz SG
    Lancet Psychiatry; 2021 Apr; 8(4):260-261. PubMed ID: 33713623
    [No Abstract]   [Full Text] [Related]  

  • 16. Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada.
    Jones AA; Gicas KM; Seyedin S; Willi TS; Leonova O; Vila-Rodriguez F; Procyshyn RM; Smith GN; Schmitt TA; Vertinsky AT; Buchanan T; Rauscher A; Lang DJ; MacEwan GW; Lima VD; Montaner JSG; Panenka WJ; Barr AM; Thornton AE; Honer WG
    PLoS Med; 2020 Jul; 17(7):e1003172. PubMed ID: 32628679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baclofen for alcohol use disorder.
    Agabio R; Saulle R; Rösner S; Minozzi S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012557. PubMed ID: 36637087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restructuring personal networks with a Motivational Interviewing social network intervention to assist the transition out of homelessness: A randomized control pilot study.
    Kennedy DP; Osilla KC; Hunter SB; Golinelli D; Maksabedian Hernandez E; Tucker JS
    PLoS One; 2022; 17(1):e0262210. PubMed ID: 35061795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: the SHARPS study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; Price T; Schofield J; MacLennan G
    Harm Reduct J; 2022 Feb; 19(1):10. PubMed ID: 35120539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitatively and quantitatively evaluating harm-reduction goal setting among chronically homeless individuals with alcohol dependence.
    Collins SE; Grazioli VS; Torres NI; Taylor EM; Jones CB; Hoffman GE; Haelsig L; Zhu MD; Hatsukami AS; Koker MJ; Herndon P; Greenleaf SM; Dean PE
    Addict Behav; 2015 Jun; 45():184-90. PubMed ID: 25697724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.